Real-time polymerase chain reaction

News and Video Search Results

News coverage

Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial

GlobeNewswire 20 May 2024

Mainz Biomed Presented Industry Leading Results: 97% Sensitivity for Colorectal Cancer, 82% for Advanced Precancerous..

Global Companion Diagnostics Industry Research 2024: Epigenomics-Based Companion Diagnostics, Advancing Biomedical Imaging Fueling Growth - Forecast to 2033
GlobeNewswire 20 May 2024
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
EQS Group 07 May 2024
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region
GlobeNewswire 06 May 2024
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next-Gen CRC Test
EQS Group 25 Apr 2024

0 shares 1 views

You might like

Real-time polymerase chain reaction media coverage

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic

GlobeNewswire 25 Apr 2024

· *Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class..

Advertisement

More coverage

Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment

EQS Group 19 Mar 2024

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous
19.03.2024 / 13:01 CET/CEST
The issuer is solely responsible for..

Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
EQS Group 18 Mar 2024
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
EQS Group 12 Mar 2024
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
EQS Group 05 Mar 2024
Respiratory Syncytial Virus Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F
GlobeNewswire 04 Mar 2024